Cargando…
HIV and SARS-CoV-2 Pathogenesis and Vaccine Development
Autor principal: | Fleury, Herve |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9781173/ https://www.ncbi.nlm.nih.gov/pubmed/36560600 http://dx.doi.org/10.3390/v14122598 |
Ejemplares similares
-
SARS-CoV-2: To be or not to be vaccinated?
por: Beauchet, Olivier
Publicado: (2021) -
Special Issue “SARS-CoV-2: Epidemiology and Pathogenesis”: Editorial
por: Calistri, Paolo, et al.
Publicado: (2023) -
The Improbability of the Rapid Development of a Vaccine for SARS-CoV-2
por: Morris, Kevin V.
Publicado: (2020) -
Development, Safety, Issues, and Challenges of the SARS-CoV-2 Vaccine
por: Matsuzaka, Yasunari, et al.
Publicado: (2023) -
Beyond SARS-CoV2, the role of viruses in the pathogenesis of hematologic malignancies
por: Wiestner, Adrian
Publicado: (2022)